Evaluation of a multi-marker immunomagnetic enrichment assay for the quantification of circulating melanoma cells
Open Access
- 15 September 2012
- journal article
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 10 (1) , 192
Abstract
Background: Circulating melanoma cells (CMCs) are thought to be valuable in improving measures of prognosis in melanoma patients and may be a useful marker of residual disease to identify non-metastatic patients requiring adjuvant therapy. We investigated whether immunomagnetic enrichment targeting multiple markers allows more efficient enrichment of CMCs from patient peripheral blood than targeting a single marker. Furthermore, we aimed to determine whether the number of CMCs in patient blood was associated with disease stage. Methods: We captured CMCs by targeting the melanoma associated markers MCSP and MCAM as well as the melanoma stem cell markers ABCB5 and CD271, both individually and in combination, by immunomagnetic enrichment. CMCs were enriched and quantified from the peripheral blood of 10 non-metastatic and 13 metastatic melanoma patients. Results: Targeting all markers in combination resulted in the enrichment of more CMCs than when any individual marker was targeted (p < 0.001-0.028). Furthermore, when a combination of markers was targeted, a greater number of CMCs were enriched in metastatic patients compared with non-metastatic patients (p = 0.007). Conclusions: Our results demonstrated that a combination of markers should be targeted for optimal isolation of CMCs. In addition, there are significantly more CMCs in metastatic patients compared with non-metastatic patients and therefore quantification of CMCs may prove to be a useful marker of disease progression.Keywords
This publication has 50 references indexed in Scilit:
- Circulating tumour cells in non-metastatic breast cancer: a prospective studyThe Lancet Oncology, 2012
- Mutation analysis of BRAF and KIT in circulating melanoma cells at the single cell levelBritish Journal of Cancer, 2012
- Isolation of tumorigenic circulating melanoma cellsBiochemical and Biophysical Research Communications, 2010
- Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271Nature, 2010
- Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapiesBreast Cancer Research and Treatment, 2008
- Detection of Mutations inEGFRin Circulating Lung-Cancer CellsNew England Journal of Medicine, 2008
- Cytotoxicity of the matrix metalloproteinase–activated anthrax lethal toxin is dependent on gelatinase expression and B-RAF status in human melanoma cellsMolecular Cancer Therapeutics, 2008
- Identification of cells initiating human melanomasNature, 2008
- Active versus passive mechanisms in metastasis: do cancer cells crawl into vessels, or are they pushed?The Lancet Oncology, 2007
- Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast CancerNew England Journal of Medicine, 2004